Epoetin alfa prevents, treats chemotherapy-induced anemia

07/19/2013 | MedPage Today (free registration)

Prophylactic epoetin alfa eased anemia during aggressive chemotherapy for breast cancer, a study found. However, 7% of the epoetin alfa-treated patients had thrombotic events, compared with 3% in a control group. "With the exception of this risk, erythropoiesis-stimulating agents appear to be safe drugs for the treatment of chemotherapy-induced anemia or the primary prevention of anemia in patients with intensive dose-dense chemotherapy regimens," according to the report in the Journal of the National Cancer Institute.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC